{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T23:05:26Z","timestamp":1769814326499,"version":"3.49.0"},"reference-count":229,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1586\/14787210.2.4.533","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T08:49:19Z","timestamp":1105606159000},"page":"533-557","source":"Crossref","is-referenced-by-count":23,"title":["Treatment of Lyme disease: a medicolegal assessment"],"prefix":"10.1586","volume":"2","author":[{"given":"Lorraine","family":"Johnson","sequence":"first","affiliation":[{"name":"California Lyme Disease Association, P.O. Box 1423, Ukiah, CA 95482, USA. lbj1@pacbell.net"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael B","family":"Stricker","sequence":"additional","affiliation":[{"name":"California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA. rstricker@usmamed.com"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-3-374"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530450047031"},{"key":"e_1_2_1_4_1","unstructured":"\u2022Evidence that coinfection increases the severity of Lyme disease."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.2001.11813695"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3024.2003.00605.x"},{"issue":"4","key":"e_1_2_1_7_1","first-page":"364","volume":"52","author":"Guner ES","year":"1996","unstructured":"Guner ES. Complement evasion by the Lyme disease spirochete Borrelia burgdorfiri grown in host-derived tissue cocultures: role of fibronectin in complement-resistance. aperientia 52(4), 364\u2013372 (1996).","journal-title":"Borrelia burgdorfiri"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011870"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","unstructured":"Rhen M Eriksson S Clements M Bergstrom S Normark SJ. The basis of persistent bacterial infections. Trends Microbial. 11(2) 80\u201386 (2003).","DOI":"10.1016\/S0966-842X(02)00038-0"},{"key":"e_1_2_1_10_1","unstructured":"\u2022Excellent review of the mechanisms of chronic infection."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-9877(03)00060-4"},{"key":"e_1_2_1_12_1","unstructured":"\u2022Seminal analysis of the Lymedisease epidemic."},{"issue":"1","key":"e_1_2_1_13_1","volume":"52","author":"Stricker R","year":"2004","unstructured":"Stricker R, Moore D, Winger E. Clinical and immunologic evidence for the transmission of Lyme disease through intimate human contact. J. Invest. Med 52(1), S151 (2004).","journal-title":"J. Invest. Med"},{"issue":"4","key":"e_1_2_1_14_1","first-page":"298","volume":"30","author":"Nadelman RB","year":"1990","unstructured":"Nadelman RB, Sherer C, Mack L, Pavia CS, Wormser GP Survival of Borrelia burgdorferi in human blood stored under blood banking conditions. Transfusion 30(4), 298\u2013301 (1990).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)01021-8"},{"key":"e_1_2_1_16_1","unstructured":"Centers for Disease Control and Prevention (CDC). Recommendations for the use of a Lyme disease vaccine. Morb. Mortal. Wkly Rep. 48(RR-7) (1999)."},{"key":"e_1_2_1_17_1","author":"Centers for Disease Control and Prevention (CDC)","year":"2004","unstructured":"Centers for Disease Control and Prevention (CDC). Lyme Disease \u2014 USA, 2001\u20132002. Morb. Mortal. Wkly Rep. 53(17),365-369 (2004).","journal-title":"Morb. Mortal. Wkly Rep"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107123450202"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)82271-1"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.6.2143"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.11.1571"},{"key":"e_1_2_1_22_1","unstructured":"\u2022Excellent review of neuropsychiatric symptoms in Lyme disease."},{"issue":"6","key":"e_1_2_1_23_1","first-page":"325","volume":"183","author":"Lebech AM","year":"1994","unstructured":"Lebech AM, Hansen K, Wilske B, Theisen M. Taxonomic classification of 29 Borrelia burgdorferi strains isolated from patients with Lyme borreliosis: a comparison of five different phenotypic and genotypic typing schemes. Med Microbid Immund (Berlin) 183(6), 325\u2013341 (1994).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(95)71669-3"},{"issue":"11","key":"e_1_2_1_25_1","first-page":"2010","volume":"45","author":"Coyle PK","year":"1995","unstructured":"Coyle PK, Schutzer SE, Deng Z, et al Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease. Neurology 45(11), 2010\u20132015 (1995).","journal-title":"Borrelia burgdorferi-specific"},{"key":"e_1_2_1_26_1","author":"Food and Drug Administration","year":"1999","unstructured":"Food and Drug Administration. Lyme disease test kits: potential for misdiagnosis. FDA Med Bull (1999).","journal-title":"FDA Med Bull"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)00217-9"},{"issue":"4","key":"e_1_2_1_28_1","first-page":"1249","volume":"40","author":"Liveris D","year":"2002","unstructured":"Liveris D, Wang G, Girao G, et al Quantitative detection of Borrelia burgdorferi in 2 mm skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin. Microbial. 40(4), 1249\u20131253 (2002).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_29_1","first-page":"13","author":"Zore A","year":"2002","unstructured":"Zore A, Ruzic-Sabllic E, Maraspin V, et al. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Wien Klin. Wochenschr. 114(13\u201314), 606\u2013609 (2002).","journal-title":"Wien Klin. Wochenschr"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.8.1961-1963.1993"},{"issue":"8685","key":"e_1_2_1_31_1","first-page":"312","volume":"335","author":"Schutzer SE","year":"1990","unstructured":"Schutzer SE, Coyle PK, Belman AL, et al. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 335(8685), 312\u2013315 (1990).","journal-title":"Borrelia burgdorferi"},{"issue":"6","key":"e_1_2_1_32_1","first-page":"355","volume":"17","author":"Preac-Mursic V","year":"1989","unstructured":"Preac-Mursic V, Weber K, Pfister HW, et al. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 17(6), 355\u2013359 (1989).","journal-title":"Borrelia burgdorferi"},{"issue":"3","key":"e_1_2_1_33_1","first-page":"218","volume":"24","author":"Mursic VP","year":"1996","unstructured":"Mursic VP, Wanner G, Reinhardt S, Wilske B, Busch U, Marget W Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection 24(3), 218\u2013226 (1996).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.3.537-543.1997"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(03)00090-7"},{"key":"e_1_2_1_36_1","first-page":"261","article-title":"The existence of chronic Lyme disease. Curr. Treat","volume":"3","author":"Donta ST","year":"2001","unstructured":"Donta ST. The existence of chronic Lyme disease. Curr. Treat. Op. Infect. Dis. 3, 261\u2013262 (2001).","journal-title":"Op. Infect. Dis"},{"issue":"1","key":"e_1_2_1_37_1","volume":"25","author":"Donta ST","year":"1997","unstructured":"Donta ST. Tetracycline therapy for chronic Lyme disease. Clin. Infect. Dis.25\\(Suppl. 1), S52\u2014S56 (1997).","journal-title":"Clin. Infect. Dis"},{"issue":"4","key":"e_1_2_1_38_1","first-page":"934","volume":"78","author":"Craft JE","year":"1986","unstructured":"Craft JE, Fischer DK, Shimamoto GT, et al. Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J. Clin. Invest. 78(4), 934\u2013939 (1986).","journal-title":"Borrelia burgdorferi"},{"issue":"6","key":"e_1_2_1_39_1","first-page":"739","volume":"28","author":"Coyle PK","year":"1990","unstructured":"Coyle PK, Schutzer SE, Belman AL, Krupp LB, Golightly MG. Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: detection of Borrelia-specific and-nonspecific complexes. Ann. Neural. 28(6), 739\u2013744 (1990).","journal-title":"Borrelia burgdorferi"},{"issue":"8","key":"e_1_2_1_40_1","first-page":"2033","volume":"34","author":"Jam VK","year":"1996","unstructured":"Jam VK, Hilton E, Maytal J, Dorante G, Ilowite NT, Sood SK. Immunoglobulin M immunoblot for diagnosis of Borrelia burgdorferi infection in patients with acute facial palsy. J. Clin. Microbial. 34(8), 2033\u20132035 (1996).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.5.1489"},{"key":"e_1_2_1_42_1","volume":"2","author":"The International Lyme and Associated Diseases Society (ILADS)","year":"2004","unstructured":"The International Lyme and Associated Diseases Society (ILADS). Evidence-based guidelines for the management of Lyme disease. Expert Rev. Anti-infect. The,: 2(Suppl.), S1\u2014S13 (2004).","journal-title":"Expert Rev. Anti-infect. The"},{"key":"e_1_2_1_43_1","unstructured":"\u2022First comprehensive guidelines for thediagnosis and treatment of Lyme disease."},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.2.419-427.1995"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.2.370-376.1992"},{"key":"e_1_2_1_46_1","unstructured":"\u2022Excellent review of Lyme disease serodiagnosis."},{"issue":"7","key":"e_1_2_1_47_1","first-page":"1148","volume":"25","author":"Rawlings JA","year":"1987","unstructured":"Rawlings JA, Fournier PV, Teltow GJ. Isolation of Borrelia spirochetes from patients in Texas. J. Clin. Microbial 25(7), 1148\u20131150 (1987).","journal-title":"Borrelia spirochetes"},{"issue":"1","key":"e_1_2_1_48_1","first-page":"1","volume":"34","author":"Aguero-Rosenfeld ME","year":"1996","unstructured":"Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP Evolution of the serologic response to Borrelia burgdorfiri in treated patients with culture-confirmed erythema migrans. J. Clin. Microbial 34(1), 1\u20139 (1996).","journal-title":"Borrelia burgdorfiri"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.12.3090-3095.1993"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80097-7"},{"issue":"6","key":"e_1_2_1_51_1","first-page":"2191","volume":"38","author":"Straubinger RK","year":"2000","unstructured":"Straubinger RK. PCR-based quantification of Borrelia burgdorfiri organisms in canine tissues over a 500-day postinfection period. J. Clin. Microbial 38(6), 2191\u20132199 (2000).","journal-title":"Borrelia burgdorfiri"},{"key":"e_1_2_1_52_1","unstructured":"\u2022Evidence for persistent Lyme disease in dogs."},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01713336"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.2.346"},{"key":"e_1_2_1_55_1","first-page":"1","author":"Centers for Disease Control and Prevention (CDC)","year":"1997","unstructured":"Centers for Disease Control and Prevention (CDC). Case definition for infectious conditions under public health surveillance (Lyme disease surveillance case definition). Morb. Mortal. Wkly Rep. 46(RR10,1\u20133), 15\u201316 (1997).","journal-title":"Morb. Mortal. Wkly Rep"},{"issue":"6","key":"e_1_2_1_56_1","first-page":"651","volume":"107","author":"Porcella SF","year":"2004","unstructured":"Porcella SF, Schwan TG. Borrelia burgdorfiri and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms. J. Clin. Invest. 107(6), 651\u2013656 (2004).","journal-title":"Borrelia burgdorfiri"},{"key":"e_1_2_1_57_1","unstructured":"\u2022Good description of the complexity of Borrelia burgdmferi."},{"issue":"2","key":"e_1_2_1_58_1","first-page":"440","volume":"166","author":"Georgilis K","year":"1992","unstructured":"Georgilis K, Peacocke M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorfiri, from ceftriaxone in vitro. J. Infect. Dis. 166(2), 440\u2013444 (1992).","journal-title":"Borrelia burgdorfiri"},{"key":"e_1_2_1_59_1","first-page":"1","author":"Coyle PK","year":"1997","unstructured":"Coyle PK. Borrelia burgdorfiri infection: clinical diagnostic techniques. Immunol Invest. 26(1\u20132), 117\u2013128 (1997).","journal-title":"Borrelia burgdorfiri"},{"issue":"6","key":"e_1_2_1_60_1","first-page":"1552","volume":"40","author":"Brouqui P","year":"1996","unstructured":"Brouqui P, Badiaga S, Raoult D. Eucaryotic cells protect Borrelia burgdorfiri from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin. Antimicrob. Agents. Chemother. 40(6), 1552\u20131554 (1996).","journal-title":"Borrelia burgdorfiri"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203123261109"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.33.3.893-907.1981"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1710990404"},{"issue":"12","key":"e_1_2_1_64_1","first-page":"1131","volume":"106","author":"Brorson O","year":"1998","unstructured":"Brorson O, Brorson SH. A rapid method for generating cystic forms of Borrelia burgdorfiri, and their reversal to mobile spirochetes. Apmis 106(12), 1131\u20131141 (1998).","journal-title":"Borrelia burgdorfiri"},{"key":"e_1_2_1_65_1","unstructured":"\u2022Evidence for cell wall-deficient forms of Borrelia burgdorferi."},{"issue":"1","key":"e_1_2_1_66_1","volume":"25","author":"Aberer E","year":"1997","unstructured":"Aberer E, Koszik F, Silberer M. Why is chronic Lyme borreliosis chronic? Clin. Infect. Dis. 25\\(Suppl. 1), S64\u2014S70 (1997).","journal-title":"Clin. Infect. Dis"},{"issue":"50","key":"e_1_2_1_67_1","first-page":"584","volume":"9","author":"Zajkowska JM","year":"2000","unstructured":"Zajkowska JM, Hermanowska-Szpakowicz T, Kondrusik M, Pancewicz SA. Neurologic syndromes in Lyme disease. Pal Merkuriusz. Lek. 9(50), 584\u2013588 (2000).","journal-title":"Pal Merkuriusz. Lek"},{"issue":"50","key":"e_1_2_1_68_1","first-page":"579","volume":"9","author":"Zajkowska JM","year":"2000","unstructured":"Zajkowska JM, Hermanowska-Szpakowicz T, Pancewicz SA, Kondrusik M. Selected aspects of immunopathogenesis in Lyme disease. Pal Merkuriusz Lek. 9(50), 579\u2013583 (2000).","journal-title":"Pal Merkuriusz Lek"},{"issue":"1","key":"e_1_2_1_69_1","volume":"25","author":"Dorward DW","year":"1997","unstructured":"Dorward DW, Fischer ER, Brooks DM. Invasion and cytopathic killing of human lymphocytes by spirochetes causing Lyme disease. Clin. Infect. Dis. 25\\(Suppl. 1) S2\u2014S8 (1997).","journal-title":"Clin. Infect. Dis"},{"issue":"2","key":"e_1_2_1_70_1","first-page":"151","volume":"8","author":"Chiao JW","year":"1994","unstructured":"Chiao JW, Pavia C, Riley M, et al. Antigens of Lyme disease of spirochaete Borrelia burgdorfiri inhibits antigen or mitogen-induced lymphocyte proliferation. FEMS Immund Med. Microbial 8(2), 151\u2013155 (1994).","journal-title":"Borrelia burgdorfiri"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(96)80038-0"},{"issue":"1","key":"e_1_2_1_72_1","first-page":"111","volume":"9","author":"Stricker RB","year":"2002","unstructured":"Stricker RB, Burrascano J, Winger E. Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. Ann. Agric. Environ. Med. 9(1), 111\u2013113 (2002).","journal-title":"Ann. Agric. Environ. Med"},{"issue":"33","key":"e_1_2_1_73_1","first-page":"125","volume":"291","author":"Hunfeld KE","year":"2002","unstructured":"Hunfeld KE, Kraiczy P, Kekoukh E, Schafer V, Brade V. Standardised in vitro susceptibility testing of Borrelia burgdorfiri against well-known and newly developed antimicrobial agents \u2014 possible implications for new therapeutic approaches to Lyme disease. Int. J. Med. Microbial 291\\(Suppl. 33), 125\u2013137 (2002).","journal-title":"in vitro"},{"issue":"1","key":"e_1_2_1_74_1","first-page":"9","volume":"24","author":"Preac Mursic V","year":"1996","unstructured":"Preac Mursic V, Marget W, Busch U, Pleterski Rigler D, Hagl S. Kill kinetics of Borrelia burgdorfiri and bacterial findings in relation to the treatment of Lyme borreliosis. Infection 24(1), 9\u201316 (1996).","journal-title":"Borrelia burgdorfiri"},{"issue":"21","key":"e_1_2_1_75_1","first-page":"1195","volume":"143","author":"Henneberg JP","year":"2002","unstructured":"Henneberg JP, Neubert U. Borrelia burgdorfiri group: in vitro antibiotic sensitivity. Ora. Hetil 143(21), 1195\u20131198 (2002).","journal-title":"Borrelia burgdorfiri"},{"key":"e_1_2_1_76_1","article-title":"Lyme disease complexities","volume":"3","author":"Burrascano J","year":"2003","unstructured":"Burrascano J. Lyme disease complexities. Kennett Friends Meeting, sponsored by the Lyme Disease Association of Southeastern Pennsylvania, Kennett Square, PA, USA. 3 May 2003.","journal-title":"Kennett Friends Meeting, sponsored by the Lyme Disease Association of Southeastern Pennsylvania, Kennett Square, PA, USA"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.1.62"},{"key":"e_1_2_1_78_1","unstructured":"\u2022US Food and Drug Administration view of Lyme disease testing."},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03490070073045"},{"key":"e_1_2_1_80_1","unstructured":"\u2022Review of problems with Lyme disease testing."},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1086\/314053"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.4.855"},{"issue":"1","key":"e_1_2_1_83_1","first-page":"111","volume":"35","author":"Straubinger RK","year":"1997","unstructured":"Straubinger RK, Summers BA, Chang YF, Appel MJ. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J. Clin. Microbial 35(1), 111\u2013116 (1997).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-5-199809010-00016"},{"issue":"4","key":"e_1_2_1_85_1","first-page":"667","volume":"38","author":"Pachner AR","year":"1995","unstructured":"Pachner AR, Delaney E, O'Neill T. Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system. Ann. Neural. 38(4), 667\u2013669 (1995).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_86_1","unstructured":"Rakel R (Ed.) Saunders PA USA (1997)."},{"key":"e_1_2_1_87_1","unstructured":"\u2022Excellent review of Lyme disease diagnosis and treatment."},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2001.13.1.3"},{"issue":"6","key":"e_1_2_1_89_1","volume":"107","author":"Freedman R1\\4","year":"2001","unstructured":"Freedman R1\\4. The two Lyme camps. Pediatrics 107(6), 1495 (2001).","journal-title":"Pediatrics"},{"issue":"4","key":"e_1_2_1_90_1","first-page":"277","volume":"15","author":"Magri JM","year":"2001","unstructured":"Magri JM, Johnson MT, Herring TA, Greenblatt JF. Lyme disease knowledge, beliefs, and practices of New Hampshire primary care physicians. J. Am. Board. Fam. Pract. 15(4), 277\u2013284 (2001).","journal-title":"J. Am. Board. Fam. Pract"},{"issue":"3","key":"e_1_2_1_91_1","first-page":"1069","volume":"181","author":"Straubinger RK","year":"2000","unstructured":"Straubinger RK, Straubinger AF, Summers BA, Jacobson RH. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: an experimental study. J. Infect. Dis. 181(3), 1069\u20131081 (2000).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-8-199410150-00002"},{"key":"e_1_2_1_93_1","unstructured":"Liegner KB. Culture confirmed treatment failure of cefotaxime and minocycline in a case of Lyme meningoencephalomyelitis. In: Program and abstracts of the Fifth International Conference on Lyme Borreliosis. Arlington VA USA (1992)."},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1991.00530230033017"},{"issue":"11","key":"e_1_2_1_95_1","first-page":"1621","volume":"36","author":"Haupl T","year":"1993","unstructured":"Haupl T, Hahn G, Rittig M, et al. Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum. 36(11), 1621\u20131626 (1993).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_96_1","doi-asserted-by":"crossref","unstructured":"Hassler D Riedel K Zorn J Preac-Mursic V. Pulsed high-dose cefotaxime therapy in refractory Lyme borreliosis. Lancet 338(8760) 193 (1991).","DOI":"10.1016\/0140-6736(91)90188-U"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.2.311"},{"key":"e_1_2_1_98_1","unstructured":"Liegner KB. Chronic persistent infection and chronic persistent denial of chronic persistent infection in Lyme disease. Annual Lyme Disease Scientific Conference. Atlantic City NJ USA. May 5\u20136 1993."},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040908"},{"issue":"5","key":"e_1_2_1_100_1","first-page":"1127","volume":"39","author":"Kersten A","year":"1995","unstructured":"Kersten A, Poitschek C, Rauch S, Aberer E. Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob. Agents. Chemother. 39(5), 1127\u20131133 (1995).","journal-title":"Borrelia"},{"issue":"3","key":"e_1_2_1_101_1","first-page":"155","volume":"13","author":"Preac-Mursic V","year":"1993","unstructured":"Preac-Mursic V, Pfister HW, Spiegel H, et al. First isolation of Borrelia burgdorferi from an iris biopsy. J. Clin. Neuroophthalmol 13(3), 155\u2013161 (1993).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-1026"},{"key":"e_1_2_1_103_1","doi-asserted-by":"crossref","unstructured":"Shadick NA Phillips CB Sangha O et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann. Intern. Med. 131(12) 919\u2013926 (1999).","DOI":"10.7326\/0003-4819-131-12-199912210-00003"},{"key":"e_1_2_1_104_1","article-title":"Testimony at public hearing in","author":"Fallon BA","year":"2004","unstructured":"Fallon BA. Testimony at public hearing in re Lyme disease, State of Connecticut. Department of Public Health 29th January 2004.","journal-title":"re Lyme disease, State of Connecticut. Department of Public Health 29th"},{"issue":"6","key":"e_1_2_1_105_1","volume":"11","author":"Schmid GP","year":"1989","unstructured":"Schmid GP. Epidemiology and clinical similarities of human spirochetal diseases. Rev. Infect. Dis. 11\\(Suppl. 6), S1460\u2014S1469 (1989).","journal-title":"Rev. Infect. Dis"},{"key":"e_1_2_1_106_1","unstructured":"Tierney LM McPhee SJ Papadakis MA (Eds) McGraw Hill NY USA (2003)."},{"key":"e_1_2_1_107_1","unstructured":"Mermin L (Ed.) Madison WI USA (1991)."},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01780668"},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.2.167"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.5025\/hansen.70.151"},{"issue":"4","key":"e_1_2_1_111_1","first-page":"405","volume":"68","author":"Shaw IN","year":"2000","unstructured":"Shaw IN, Natrajan MM, Rao GS, Jesudasan K, Christian M, Kavitha M. Long-term follow-up of muhibacillary leprosy patients with high BI treated with WHO\/MDT regimen for a fixed duration of 2 years. Int. J. Lepr. Mycobact. Dis. 68(4), 405\u2013409 (2000).","journal-title":"Int. J. Lepr. Mycobact. Dis"},{"key":"e_1_2_1_112_1","doi-asserted-by":"crossref","unstructured":"Small PM Fujiwara PI. Management of tuberculosis in the USA. N Eng-1 J. Med 345(3) 189\u2013200 (2001).","DOI":"10.1056\/NEJM200107193450307"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.12.10.1609"},{"key":"e_1_2_1_114_1","unstructured":"\u2022Excellent analysis of the Lymedisease controversy."},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(94)91105-3"},{"issue":"3","key":"e_1_2_1_116_1","first-page":"225","volume":"31","author":"Oksi J","year":"1999","unstructured":"Oksi J, Marjamaki M, Nikoskelainen J, Viljanen MK. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann. Med. 31(3), 225\u2013232 (1999).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000071227.23769.9E"},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7180.391"},{"key":"e_1_2_1_119_1","unstructured":"\u2022Short but cogent analysis of the interestsof different stakeholders in the process of drafting guidelines."},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(03)00075-0"},{"issue":"2","key":"e_1_2_1_121_1","volume":"26","author":"Morriem E","year":"2001","unstructured":"Morriem E. From the clinics to the courts: the role evidence should play in litigating medical care. J. Health Polit. Policy Law 26(2), 409 (2001).","journal-title":"J. Health Polit. Policy Law"},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000077046.67754.60"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.1.43"},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0098858800002690"},{"key":"e_1_2_1_125_1","unstructured":"\u2022Excellent overview of the distinction between experimental and nonexperimental medicine the weight that should be afforded to different types of evidence and the need for informed consent."},{"key":"e_1_2_1_126_1","article-title":"New York State Assembly Standing Committee On Health, public hearing: chronic Lyme disease and long-term antibiotic treatment","author":"Britton C","year":"2001","unstructured":"Britton C. Remarks before the NYS Assembly Committee on Health chaired by Richard Gottfried. New York State Assembly Standing Committee On Health, public hearing: chronic Lyme disease and long-term antibiotic treatment. NY, USA, 27th November 2001.","journal-title":"NY, USA, 27th"},{"key":"e_1_2_1_127_1","unstructured":"Zeuzem S. A comparison of standard treatment versus dynamically individualized treatment in patients with chronic hepatitis C. 54th Annual Meeting of the American Association for the Study of Liver Diseases MA USA. October 24\u201328 2003."},{"key":"e_1_2_1_128_1","doi-asserted-by":"publisher","DOI":"10.1086\/319347"},{"key":"e_1_2_1_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7012(02)00186-0"},{"issue":"7","key":"e_1_2_1_130_1","first-page":"2215","volume":"37","author":"Schouls LM","year":"1999","unstructured":"Schouls LM, Van De Poll, Rijpkema SG, Schot CS. Detection and identification of Ehrlichia,Borrelia burgdorferi sensu lato, and Bartonella spp. in Dutch Ixodes ricinus ticks. J Clin. Microbial 37(7), 2215\u20132222 (1999).","journal-title":"Ehrlichia,Borrelia burgdorferi"},{"key":"e_1_2_1_131_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-49-10-911"},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007263230402"},{"key":"e_1_2_1_133_1","author":"Field M","year":"1992","unstructured":"Field M, Lohr K (Eds), Institute of Medicine. Guidelines for clinical practice: from development to use. National Academy Press, Washington, DC, USA (1992). Excellent overview of the relative roles of evidence and consensus in medical practice and how to guard against bias in the drafting of treatment guidelines.","journal-title":"Guidelines for clinical practice: from development to use"},{"key":"e_1_2_1_134_1","author":"Hitt J","year":"2001","unstructured":"Hitt J. The year in ideas: A to Z evidence-based medicine. New York Times December 9 (2001).","journal-title":"New York Times"},{"key":"e_1_2_1_135_1","author":"Wennberg JE","year":"2002","unstructured":"Wennberg JE, Fisher JS, Skinner JS. Geography and the debate over Medicare reform. Health. Aff: (Millwood) (Suppl. Web Exclusives), W96-114 (2002).","journal-title":"Health. Aff: (Millwood"},{"key":"e_1_2_1_136_1","unstructured":"\u2022Includes an excellent analysis of small-areavariations caused by patient preference issues and the appropriate way to address this variation (outcomes research and informed patient consent)."},{"key":"e_1_2_1_137_1","author":"Arlen J","year":"2003","unstructured":"Arlen J, MacLeod W Malpractice liability for physicians and managed care organizations. NY Uni. Law Rev. (2003).","journal-title":"Uni. Law Rev"},{"key":"e_1_2_1_138_1","unstructured":"\u2022Excellent analysis of negligence liability forphysicians and managed care organizations and the essential role that such sanctions play in regulating noncontractable postcontractual medical actions to establish optimal care."},{"key":"e_1_2_1_139_1","volume-title":"IOM and AHRQ Workshop","author":"Mulrow C","year":"2000","unstructured":"Mulrow C, Lohr K. Proof and Policy from Medical Research Evidence Journal of Health Politics, Policy and Law, entitled Evidence: its meanings in health care and in law. (Summary of the 10 April 2000 IOM and AHRQ Workshop). J. Health Polit. Policy Law (2000)."},{"key":"e_1_2_1_140_1","unstructured":"\u2022Analysis of the subjective contribution of judgment values probability and uncertainty in medical decision making."},{"key":"e_1_2_1_141_1","unstructured":"Muir Gray J. Evidence-Based Healthcare. How to Make Health Policy and Management Decisions. Churchill Livingstone London UK (1997)."},{"key":"e_1_2_1_142_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530070068032"},{"key":"e_1_2_1_143_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-1-199801010-00007"},{"key":"e_1_2_1_144_1","author":"Martinez B","year":"2000","unstructured":"Martinez B. Care guidelines used by insurers face scrutiny. Wall Street Journah September 14 (2000).","journal-title":"Wall Street Journah"},{"key":"e_1_2_1_145_1","unstructured":"Bransfield R 1VYS Assembly Committee on Health chaired by Richard Gottfried. Albany NY USA 27 November 2001."},{"key":"e_1_2_1_146_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2002.tb04428.x"},{"key":"e_1_2_1_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)02171-6"},{"issue":"2","key":"e_1_2_1_148_1","first-page":"845","volume":"78","author":"Silver W The Inadequacy of state legislative responses to ERISA preemption of managed care liability","year":"2003","unstructured":"Silver W The Inadequacy of state legislative responses to ERISA preemption of managed care liability. NY Uni. Law Rev. 78(2), 845\u2013873 (2003).","journal-title":"Uni. Law Rev"},{"key":"e_1_2_1_149_1","volume":"6","author":"Stolberg S","year":"2003","unstructured":"Stolberg S. Study says clinical guides often hide ties of doctors. New York Times 6 February (2003).","journal-title":"New York Times"},{"key":"e_1_2_1_150_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.5.612"},{"key":"e_1_2_1_151_1","doi-asserted-by":"publisher","DOI":"10.2307\/3312867"},{"key":"e_1_2_1_152_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7182.527"},{"key":"e_1_2_1_153_1","doi-asserted-by":"crossref","unstructured":"Fletcher S Fletcher R. Development of clinical guidelines. Lancet 352(9144) 1876 (1998)","DOI":"10.1016\/S0140-6736(05)60393-5"},{"key":"e_1_2_1_154_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7180.391"},{"key":"e_1_2_1_155_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720X.2002.tb00386.x"},{"key":"e_1_2_1_156_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7182.527"},{"key":"e_1_2_1_157_1","article-title":"Approved Jury Instructions","author":"California Jury Instruction Civil Committee","year":"2002","unstructured":"California Jury Instruction Civil Committee. Duty of Physicians. In: California Jury Instructions, Civil: Book Of Approved Jury Instructions. West Publishing Co., MN, USA (2002).","journal-title":"West Publishing Co., MN, USA"},{"issue":"3","key":"e_1_2_1_158_1","first-page":"821","volume":"37","author":"Mello M","year":"2002","unstructured":"Mello M. Using statistical evidence to prove the malpractice standard of care: bridging legal, clinical, and statistical thinking. Wake Forest Law Rev. 37(3), 821\u2013859 (2002).","journal-title":"Wake Forest Law Rev"},{"key":"e_1_2_1_159_1","article-title":"Approved Jury Instructions","author":"California Jury Instruction Civil Committee","year":"2002","unstructured":"California Jury Instruction Civil Committee. Medical negligence \u2014 standard of care determined by expert testimony. In: California Jury Instructions, Civil: Book of Approved Jury Instructions. West Publishing Co., MN, USA (2002).","journal-title":"West Publishing Co., MN, USA"},{"key":"e_1_2_1_160_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7019.1517"},{"key":"e_1_2_1_161_1","doi-asserted-by":"publisher","DOI":"10.1215\/03616878-26-2-249"},{"key":"e_1_2_1_162_1","article-title":"California Jury Instructions, Civil. Book of Approved Jury Instructions","author":"California Jury Instruction Civil Committee","year":"2002","unstructured":"California Jury Instruction Civil Committee. Alternative methods of diagnosis or treatment. In: California Jury Instructions, Civil. Book of Approved Jury Instructions. West Publishing Co., St. Paul, MN, USA (2002).","journal-title":"West Publishing Co., St. Paul, MN, USA"},{"key":"e_1_2_1_163_1","unstructured":"Leech v. Bralliar 275 E Supp. 897 (D. Ariz. 1967)."},{"key":"e_1_2_1_164_1","doi-asserted-by":"crossref","unstructured":"Natole v. Michigan Board of Medicine (File no. 96\u2013015560 AA-2) (1998) (2001).","DOI":"10.2307\/1290058"},{"key":"e_1_2_1_165_1","article-title":"Defensive Medicine and Medical Malpractice","author":"Office of Technology Assessment (US Congress)","year":"1994","unstructured":"Office of Technology Assessment (US Congress). Defensive Medicine: definition and causes. In: Defensive Medicine and Medical Malpractice. USA Government Printing Office, Washington, DC, USA (1994). Interesting analysis of defensive versus nondefensive medicine and in what situations it is appropriate for a physician to employ defensive medicine to improve treatment outcomes.","journal-title":"USA Government Printing Office, Washington, DC, USA"},{"key":"e_1_2_1_166_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-9-199611010-00010"},{"key":"e_1_2_1_167_1","article-title":"Effective Clin. Prac","author":"Amanda R","year":"1999","unstructured":"Amanda R, Marcia A, Richard WD, et al. What is a good decision? Effective Clin. Prac. July\/August (1999).","journal-title":"July\/August"},{"key":"e_1_2_1_168_1","unstructured":"Cobbs v. Grant 104 Cal. Rptr. 505 (Cal. 1972)."},{"key":"e_1_2_1_169_1","unstructured":"Matthies v. Mastromonaco 733 A. 2d 456 (N.J. 1999)."},{"key":"e_1_2_1_170_1","doi-asserted-by":"crossref","unstructured":"Mathis v. Morrissey 13 Cal. Rpm 2d 819 (1992).","DOI":"10.1080\/10598650.1992.11510192"},{"issue":"3","key":"e_1_2_1_171_1","first-page":"925","volume":"37","author":"Wennburg JE","year":"2002","unstructured":"Wennburg JE, Peters GP Unwarranted variations in the quality of healthcare: can the law help medicine provide a remedy\/remedies? Wake Forest Law Rev. 37(3), 925\u2013941 (2002).","journal-title":"Wake Forest Law Rev"},{"key":"e_1_2_1_172_1","first-page":"2","volume":"6","author":"Wang M","year":"1994","unstructured":"Wang M. Resurgent Paternalism. Virtual Mentor-Ethics J. Am. Med. Assoc. 6(2) (1994).","journal-title":"Am. Med. Assoc"},{"key":"e_1_2_1_173_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-9-200211050-00028"},{"key":"e_1_2_1_174_1","unstructured":"Hughes v. Blue Cross of Northern Califirnia 263 Cal. Rptr. 850 (1989)"},{"key":"e_1_2_1_175_1","unstructured":"Wickline v. State of California 239 Cal. Rptr. 810 (1986)"},{"key":"e_1_2_1_176_1","unstructured":"Wilson v. Blue Cross of Southern California 271 Cal. Rpm 876 (1990)."},{"key":"e_1_2_1_177_1","unstructured":"\u2022The Wilson court points out that language in Wickline suggesting that liability rests solely within the treating physician's responsibility constitutes nonbinding dicta and holds that an insurance review company may be held responsible when its conduct is a substantial factor in the plaintiff's injury or death."},{"key":"e_1_2_1_178_1","unstructured":"Van Vactor v. Blue Cross Assoc. 365 N.E.2d 638 645 (Ill. App. Ct. 1977)."},{"key":"e_1_2_1_179_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720X.2001.tb00361.x"},{"key":"e_1_2_1_180_1","unstructured":"Murray v. Chesapeake No. 07C99000129mm. (Cecil county MD 2000)."},{"key":"e_1_2_1_181_1","unstructured":"Sarchett v. Blue Shield of California 223 Cal. Rptr. 76 (1987)."},{"key":"e_1_2_1_182_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01780670"},{"issue":"3","key":"e_1_2_1_183_1","first-page":"454","volume":"21","author":"Asch ES","year":"1994","unstructured":"Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J. Rheumatol. 21(3), 454\u2013461 (1994).","journal-title":"J. Rheumatol"},{"key":"e_1_2_1_184_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011223232102"},{"issue":"2","key":"e_1_2_1_185_1","first-page":"387","volume":"144","author":"Breier F","year":"2001","unstructured":"Breier F, Khanakah G, Stanek G, et al. Isolation and polymerase chain reaction typing of Borrelia afielii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus. Br. J. Dermatol. 144(2), 387\u2013392 (2001).","journal-title":"Borrelia afielii"},{"key":"e_1_2_1_186_1","first-page":"24","article-title":"Disorders","author":"Horowitz R","year":"2000","unstructured":"Horowitz R. Chronic persistent Lyme borreliosis: PCR evidence of chronic infection despite extended antibiotic therapy \u2014 a retrospective review. 13th International Scientific Conference on Lyme Disease and Other Tick-Borne Disorders. CT, USA 24\u201326 March 2000.","journal-title":"CT, USA"},{"issue":"5","key":"e_1_2_1_187_1","first-page":"347","volume":"24","author":"Bayer ME","year":"1996","unstructured":"Bayer ME, Zhang L, Bayer MH. Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases. Infection 24(5), 347\u2013353 (1996).","journal-title":"Borrelia burgdorferi"},{"key":"e_1_2_1_188_1","author":"Burrascano J","year":"1993","unstructured":"Burrascano J. Failure of aggressive antibiotic therapy to protect the placenta from invasion by B burgdorferi in a pregnant patient with Lyme Borreliosis. 6th Annual International Science Conference on Lyme Disease and other Tick-borne Diseases. (1993) (Abstract).","journal-title":"Tick-borne Diseases"},{"key":"e_1_2_1_189_1","first-page":"238","article-title":"Chronic septic arthritis caused by","volume":"297","author":"Battafarano DF","year":"1993","unstructured":"Battafarano DF, Combs JA, Enzenauer RJ, Fitzpatrick JE. Chronic septic arthritis caused by Borrelia burgdorferi. Clin. Orthop. 297,238\u2013241 (1993).","journal-title":"Borrelia burgdorferi. Clin. Orthop"},{"key":"e_1_2_1_190_1","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.1998.11754160"},{"key":"e_1_2_1_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92624-0"},{"key":"e_1_2_1_192_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.5.1415-1416.1994"},{"key":"e_1_2_1_193_1","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050166"},{"key":"e_1_2_1_194_1","first-page":"94","article-title":"Repeated antibiotic treatment in chronic Lyme disease","volume":"6","author":"Fallon BA","year":"1999","unstructured":"Fallon BA. Repeated antibiotic treatment in chronic Lyme disease. J Spirochet Tick Borne Dis. 6,94\u2013101 (1999).","journal-title":"J Spirochet Tick Borne Dis"},{"key":"e_1_2_1_195_1","doi-asserted-by":"publisher","DOI":"10.1159\/000117104"},{"key":"e_1_2_1_196_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019048-199405000-00016"},{"key":"e_1_2_1_197_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.8.1007"},{"key":"e_1_2_1_198_1","volume":"8","author":"Connor S","year":"2003","unstructured":"Connor S. Glaxo chief: our drugs do not work on most patients. The Independent 8 December (2003).","journal-title":"The Independent"},{"issue":"7","key":"e_1_2_1_199_1","first-page":"332","volume":"176","author":"Edmonds J","year":"2002","unstructured":"Edmonds J, Day O, Bertouch J. In reply: The road to consensus: consideraton for the safe use and prescribing of C0X-2 specific inhibitors. Med J. Aust. 176(7), 332\u2013334 (2002).","journal-title":"Med J. Aust"},{"key":"e_1_2_1_200_1","unstructured":"\u2022Excellent discussion of the hazards and pitfalls of guideline development within contentious groups."},{"key":"e_1_2_1_201_1","first-page":"133","article-title":"Consensus development at NIH: What went wrong?","volume":"4","author":"Jacoby I","year":"1993","unstructured":"Jacoby I. Consensus development at NIH: What went wrong? Risk 4,133 (1993).","journal-title":"Risk"},{"key":"e_1_2_1_202_1","first-page":"139","article-title":"Resolving medical controversies","volume":"6","author":"Jacoby I","year":"1994","unstructured":"Jacoby I. Resolving medical controversies. Risk 6,139 (1994).","journal-title":"Risk"},{"key":"e_1_2_1_203_1","first-page":"313","article-title":"Dissing disclosure: just what the doctor ordered","volume":"44","author":"Morris GH","year":"2002","unstructured":"Morris GH. Dissing disclosure: just what the doctor ordered. Ariz. Law Rev. 44,313 (2002).","journal-title":"Ariz. Law Rev"},{"key":"e_1_2_1_204_1","unstructured":"\u2022Provides an extensive and well-reasoned analysis of the history current status and legal issues lurking in the doctrine of informed consent."},{"key":"e_1_2_1_205_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66718-1"},{"key":"e_1_2_2_2_1","unstructured":"Rubel J. Lyme disease symptoms and characteristics: a compilation of peer-reviewed literature reports (compilation of 19 Lyme related deaths). www.lymeinfo.net\/LDSymptoms.pdf (Accessed July 2004)"},{"key":"e_1_2_2_3_1","unstructured":"Edlow J. Tick borne diseases Lyme. eMedicine www.emedicine.com\/emerg\/topic588.htm (Accessed July 2004)"},{"key":"e_1_2_2_4_1","unstructured":"National Institute of Allergy and Infectious Diseases (National Institute of Health) profile fiscal year 2001 www.niaid.nih.gov\/publications\/NIAIDP rofile\/ (Accessed July 2004)"},{"key":"e_1_2_2_5_1","unstructured":"\u2022Excellent discussion of the hazards and pitfalls of guideline development within contentious groups."},{"key":"e_1_2_2_6_1","author":"Liegner KB","year":"2001","unstructured":"Liegner KB. Remarks before the New York State Assembly Committee on Health, Public Hearing. Chronic Lyme Disease and Long-term Antibiotic Treatment, NY, USA, 27 November 2001. www.canlyme.com\/leigner.html (Accessed July 2004)","journal-title":"Remarks before the New York"},{"key":"e_1_2_2_7_1","unstructured":"National Institute of Allergy and Infectious Diseases (National Institute of Health). Diagnosis of Lyme Disease. www.niaid.nih.gov\/dmid\/lyme\/diagnosis.ht (Accessed July 2004)"},{"key":"e_1_2_2_8_1","unstructured":"Mead P. Statement by Paul Mead MD M.P.H. Medical Epidemiologist Division of Vector-Borne Infectious Diseases National Center for Infectious Diseases Center for Disease Control and Prevention US Department of Health and Human Services on Hearing: CDC's Lyme Disease Prevention and Control Activities at public hearing in re Lyme disease State of Connecticut Department of Public Health 29 January 2004. www.hhs.gov\/aslkestify\/t040129.html (Accessed July 2004)"},{"key":"e_1_2_2_9_1","unstructured":"Rawlings J Goldhagens H. Lyme Disease Controversies. Medscape coverage of the 14th International Scientific Confirence on Lyme Disease and Other Tick-Borne Disorders. www.medscape.com\/viewprogram\/ 482_childindex (Accessed July 2004)"},{"key":"e_1_2_2_10_1","unstructured":"Lyme Disease Foundation. The controversies surrounding Lyme disease diagnosis and treatment and why it is not uncommon for patients to experience persistent symptoms despite receiving conventional' (short-term) antibiotic therapy for Lyme disease. www.lyme.orelymelighthrtcontrov.html (Accessed July 2004)"},{"key":"e_1_2_2_11_1","unstructured":"Cooper C. Safety of long-term therapy with penicillin and penicillin derivatives. Center for Drug Evaluation and Research. www.fda.gov\/cder\/drugprepare\/ penlongsafety.htm (Accessed July 2004)"},{"key":"e_1_2_2_12_1","unstructured":"Burrascano JJ. Diagnostic hints and treatment guidelines for Lyme and other tick-borne illnesses. (2002). http:\/\/www.ilads.org\/burrascano_1102.htm (Accessed July 2004)"},{"key":"e_1_2_2_13_1","unstructured":"\u2022Comprehensive guide to Lyme diseasediagnosis and treatment."},{"key":"e_1_2_2_14_1","unstructured":"The International Lyme and Associated Diseases Society (ILADS). Evaluation of antibiotic treatment in patients with persistent symptoms of Lyme disease. www.ilads.org\/position2.htm(Accessed July 2004)"},{"key":"e_1_2_2_15_1","unstructured":"\u2022Must-read rebuttal to the flawed study oflong-term' antibiotic therapy published in the N. EngL J. Med [14]."},{"key":"e_1_2_2_16_1","unstructured":"Grier T ELISA and western blot: lies that can kill you? www.centurytel.nethjs11\/bug\/blotl.htm (Accessed July 2004)"},{"key":"e_1_2_2_17_1","unstructured":"Morgan M. Independent review of managed care decisions.csha.calliealth.org\/ (Accessed July 2004)"},{"key":"e_1_2_2_18_1","unstructured":"Booth A. What proportion of healthcare is evidence based? www.shefac.uk\/schardir\/percent.html (Accessed July 2004)"},{"key":"e_1_2_2_19_1","unstructured":"\u2022Valuable compilation of discussion on evidence-based medicine from many studies and comments including the distinction between randomized clinical trial-based and compelling nonexperimental evidence."},{"key":"e_1_2_2_20_1","unstructured":"Lewis D. National guideline clearinghouse: extensive resource underused in managed care. www.managedcaremag.com\/archives\/0106\/0 106.guidelines.htm (Accessed July 2004)"},{"key":"e_1_2_2_21_1","unstructured":"Jemsek JG. Lyme disease in the Carolinas (1998) www.jemsekclinic.com\/lymedisease.php. (Accessed July 2004)"},{"key":"e_1_2_2_22_1","unstructured":"Centre for Evidence Based Medicine. What are the limitations of EBM? www.cebm.utoronto.ca\/intro\/limit.htm (Accessed July 2004)"},{"key":"e_1_2_2_23_1","first-page":"01","author":"In the Matter","year":"2003","unstructured":"In the Matter of Joseph Burrascano v. New York State Bd. for Professional Medical Conduct, Determination and Order (No. 01\u2013265) of the Hearing Committee dated November 6 2003 w3.health.state.ny.us\/opmc\/factions.nsf\/ 58220x%20%20%20%20a7f9eeaafab85 2566180058c032\/7f57f08d61de929c852 56a4a0047c6da\/$FILE\/ATTIDOPD \/1cl 45623.pdf (Accessed July 2004)","journal-title":"of Joseph Burrascano v. New York State Bd"},{"key":"e_1_2_2_24_1","unstructured":"Hamilton C. LymeNet Law Pages Lyme Related Legal Matters. Jury awards $1.7 million to Cecil teen (December 20 2000). www2Aymenet.org\/domino\/law.nsf\/0\/2d 03309dc8e1088d052569bd0061a28b?0 penDocument (Accessed July 2004)"},{"key":"e_1_2_2_25_1","unstructured":"American Medical Association Code of Medical Ethics. Current opinions with annotations 2002\u20132003. www.ama-assn.org\/apps\/pf_new\/pf_online? category= CEJA&assn = AMA&f n = mSearch&s_t = &st_p = &nth= 1 & (Accessed July 2004)"},{"key":"e_1_2_2_26_1","unstructured":"Fowler F. The role of patient preferences in medical care. www.fimdm.org\/downloads\/Patient_Pref erences_Fowler.pdf (Accessed July 2004)"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14787210.2.4.533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T20:22:15Z","timestamp":1768940535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14787210.2.4.533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":229,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1586\/14787210.2.4.533"],"URL":"https:\/\/doi.org\/10.1586\/14787210.2.4.533","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}